185
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study

, , , , , & show all
Pages 43-58 | Published online: 25 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sara Alves, João Cavaleiro Rufo & José Crispim. (2023) Economic evaluation of biological treatments in patients with severe asthma: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 23:7, pages 733-747.
Read now
Andrew N Menzies-Gow, Claire McBrien, Bindhu Unni, Celeste M Porsbjerg, Mona Al-Ahmad, Christopher S Ambrose, Karin Dahl Assing, Anna von Bülow, John Busby, Borja G Cosio, J Mark FitzGerald, Esther Garcia Gil, Susanne Hansen, Liam G aHeaney, Mark Hew, David J Jackson, Maria Kallieri, Stelios Loukides, Njira L Lugogo, Andriana I Papaioannou, Désirée Larenas-Linnemann, Wendy C Moore, Luis A Perez-de-Llano, Linda M Rasmussen, Johannes M Schmid, Salman Siddiqui, Marianna Alacqua, Trung N Tran, Charlotte Suppli Ulrik, John W Upham, Eileen Wang, Lakmini Bulathsinhala, Victoria A Carter, Isha Chaudhry, Neva Eleangovan, Ruth B Murray, Chris A Price & David B Price. (2022) Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study. Journal of Asthma and Allergy 15, pages 63-78.
Read now
William W. Busse, Juanzhi Fang, Jessica Marvel, Hengfeng Tian, Pablo Altman & Hui Cao. (2022) Uncontrolled asthma across GINA treatment steps 2 − 5 in a large US patient cohort. Journal of Asthma 59:5, pages 1051-1062.
Read now
A Bakakos, S Loukides, O S Usmani & P Bakakos. (2020) Biologics in severe asthma: the overlap endotype - opportunities and challenges. Expert Opinion on Biological Therapy 20:12, pages 1427-1434.
Read now

Articles from other publishers (9)

Nicola A. Hanania & Marc Miravitlles. (2022) Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunology and Allergy Clinics of North America 42:3, pages 657-669.
Crossref
Yuya Kimura, Maho Suzukawa, Norihiko Inoue, Shinobu Imai, Manabu Akazawa & Hirotoshi Matsui. (2021) Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use. World Allergy Organization Journal 14:11, pages 100600.
Crossref
Job J.M.H. van Bragt, Susanne Hansen, Ratko Djukanovic, Elisabeth H.D. Bel, Anneke ten Brinke, Scott S. Wagers, Anke H. Maitland-van der Zee & Celeste Porsbjerg. (2021) SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma. ERJ Open Research 7:2, pages 00064-2021.
Crossref
Armando Partida-Gaytán, Luis Torre-Bouscoulet, Marco Polo Macías, Alejandro Raimondi & Emilio Pizzichini. (2021) Mepolizumab para el tratamiento de asma grave eosinofílica. Revista Alergia México 67.
Crossref
Ioana Agache, Cezmi A. Akdis, Mubeccel Akdis, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Derek K. Chu, Stefano Del Giacco, Thomas Eiwegger, Breda Flood, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Irene Hernández‐Martín, Rebeca Knibb, Mika Mäkelä, Parameswaran Nair, Liam O’Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Oliver Pfaar, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Oscar Palomares & Marek Jutel. (2020) EAACI Biologicals Guidelines—Recommendations for severe asthma. Allergy 76:1, pages 14-44.
Crossref
Ioana Agache, Yang Song, Claudio Rocha, Jessica Beltran, Margarita Posso, Corinna Steiner, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1058-1068.
Crossref
Ioana Agache, Catalina CojanuAlexandru LaculiceanuLiliana Rogozea. (2020) Critical Points on the Use of Biologicals in Allergic Diseases and Asthma. Allergy, Asthma & Immunology Research 12:1, pages 24.
Crossref
Amlan Chakraborty & Simon G. Royce. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 97 115 .
Diego Jose Maselli & Nicola Alexander Hanania. (2019) Management of asthma COPD overlap. Annals of Allergy, Asthma & Immunology 123:4, pages 335-344.
Crossref